Walwyn Rebecca E A, Russell Amy M, Bryant Louise D, Farrin Amanda J, Wright-Hughes Alexandra M, Graham Elizabeth H, Hulme Claire, O'Dwyer John L, Latchford Gary J, Stansfield Alison J, Nagi Dinesh, Ajjan Ramzi A, House Allan O
Clinical Trials Research Unit, University of Leeds, Leeds, UK.
Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.
Trials. 2015 Aug 8;16:342. doi: 10.1186/s13063-015-0832-9.
Individuals with a learning disability (LD) are at higher risk of developing type 2 diabetes, but LD is not straightforward to define or identify, especially at the milder end of the spectrum, which makes case finding difficult. While supported self-management of health problems is now established, current material is largely educational and didactic with little that facilitates behavioural change. The interaction between the person with diabetes and others supporting their care is also largely unknown. For these reasons, there is considerable work needed to prepare for a definitive trial. The aim of this paper is to publish the abridged protocol of this preparatory work.
METHODS/DESIGN: Phase I is a prospective case-finding study (target n = 120 to 350) to identify and characterise potential participants, while developing a standardised supported self-management intervention. Phase II is a randomised feasibility trial (target n = 80) with blinded outcome assessment. Patients identified in Phase I will be interviewed and consented prior to being randomised to (1) standard treatment, or (2) supported self-management. Both arms will also be provided with an 'easy read' accessible information resource on managing type 2 diabetes. The intervention will be standardised but delivered flexibly depending on patient need, including components for the participant, a supporter, and shared activities. Outcomes will be (i) robust estimates of eligibility, consent and recruitment rates with refined recruitment procedures; (ii) characterisation of the eligible population; (iii) a standardised intervention with associated written materials, (iv) adherence and negative outcomes measures; (v) preliminary estimates of adherence, acceptability, follow-up and missing data rates, along with refined procedures; and (vi) description of standard treatment.
Our study will provide important information on the nature of type 2 diabetes in adults with LD living in the community, on the challenges of identifying those with milder LD, and on the possibilities of evaluating a standardised intervention to improve self-management in this population.
Current Controlled Trials ISRCTN41897033 (registered 21 January 2013).
学习障碍(LD)患者患2型糖尿病的风险更高,但学习障碍的定义和识别并不简单直接,尤其是在症状较轻的情况下,这使得病例发现变得困难。虽然目前已确立了对健康问题的支持性自我管理,但现有资料大多是教育性和说教性的,几乎没有促进行为改变的内容。糖尿病患者与其他提供护理支持的人员之间的互动情况也大多未知。出于这些原因,需要开展大量工作为一项确定性试验做准备。本文的目的是公布这项准备工作的简略方案。
方法/设计:第一阶段是一项前瞻性病例发现研究(目标样本量为120至350例),旨在识别和描述潜在参与者,同时制定标准化的支持性自我管理干预措施。第二阶段是一项随机可行性试验(目标样本量为80例),采用盲法评估结果。在第一阶段识别出的患者将在被随机分配到以下两组之前接受访谈并获得同意:(1)标准治疗组,或(2)支持性自我管理组。两组还将获得一份关于管理2型糖尿病的“易读”信息资源。干预措施将是标准化的,但会根据患者需求灵活实施,包括针对参与者、支持者的组成部分以及共享活动。结果将包括:(i)通过完善的招募程序对合格性、同意率和招募率进行可靠估计;(ii)对合格人群的特征描述;(iii)带有相关书面材料的标准化干预措施;(iv)依从性和负面结果测量;(v)对依从性、可接受性、随访和缺失数据率的初步估计以及完善的程序;(vi)标准治疗的描述。
我们的研究将提供有关社区中患有学习障碍的成年2型糖尿病患者的性质、识别症状较轻的学习障碍患者所面临的挑战以及评估标准化干预措施以改善该人群自我管理可能性的重要信息。
当前受控试验ISRCTN41897033(2013年1月21日注册)。